FDA 483 - Vitalant - July 24, 2019

An FDA inspection of Vitalant's Blood Bank Corporate Office in Scottsdale, AZ, revealed a significant issue with their electronic donor management system. The system failed to properly identify duplicate donor records, leading to a failure in maintaining accurate records of ineligible or deferred donors. This deficiency could potentially compromise donor eligibility screening and product safety.